Ouabain Protects Human Renal Cells Against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2017 Jul 19

PMID 28718802

Citations 3

Authors

Maria M Amaral

Magali C Girard

Romina S Alvarez

Adrienne W Paton

James C Paton

Horacio A Repetto

Flavia Sacerdoti

Cristina A Ibarra

Affiliations

Soon will be listed here.

Abstract

Hemolytic uremic syndrome (HUS) is one of the most common causes of acute renal failure in children. The majority of cases are associated with Shiga toxin (Stx)-producing (STEC). In Argentina, HUS is endemic and presents the highest incidence rate in the world. STEC strains expressing Stx type 2 (Stx2) are responsible for the most severe cases of this pathology. Subtilase cytotoxin (SubAB) is another STEC virulence factor that may contribute to HUS pathogenesis. To date, neither a licensed vaccine nor effective therapy for HUS is available for humans. Considering that Ouabain (OUA) may prevent the apoptosis process, in this study we evaluated if OUA is able to avoid the damage caused by Stx2 and SubAB on human glomerular endothelial cells (HGEC) and the human proximal tubule epithelial cell (HK-2) line. HGEC and HK-2 were pretreated with OUA and then incubated with the toxins. OUA protected the HGEC viability from Stx2 and SubAB cytotoxic effects, and also prevented the HK-2 viability from Stx2 effects. The protective action of OUA on HGEC and HK-2 was associated with a decrease in apoptosis and an increase in cell proliferation. Our data provide evidence that OUA could be considered as a therapeutic strategy to avoid the renal damage that precedes HUS.

Citing Articles

The effect of repeated passaging on the susceptibility of human proximal tubular HK-2 cells to toxic compounds.

Handl J, Capek J, Majtnerova P, Bacova J, Rousar T Physiol Res. 2020; 69(4):731-738.

PMID: 32672047 PMC: 8549898. DOI: 10.33549/physiolres.934491.

Recent Advances in Shiga Toxin-Producing Research in Latin America.

Torres A, Amaral M, Bentancor L, Galli L, Goldstein J, Kruger A Microorganisms. 2018; 6(4).

PMID: 30274180 PMC: 6313304. DOI: 10.3390/microorganisms6040100.

Shiga Toxin Therapeutics: Beyond Neutralization.

Hall G, Kurosawa S, Stearns-Kurosawa D Toxins (Basel). 2017; 9(9).

PMID: 28925976 PMC: 5618224. DOI: 10.3390/toxins9090291.

References

Lapeyraque A, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M . Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med. 2011; 364(26):2561-3. DOI: 10.1056/NEJMc1100859. View

Paton A, Beddoe T, Thorpe C, Whisstock J, Wilce M, Rossjohn J . AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature. 2006; 443(7111):548-52. DOI: 10.1038/nature05124. View

Holthouser K, Mandal A, Merchant M, Schelling J, Delamere N, Valdes Jr R . Ouabain stimulates Na-K-ATPase through a sodium/hydrogen exchanger-1 (NHE-1)-dependent mechanism in human kidney proximal tubule cells. Am J Physiol Renal Physiol. 2010; 299(1):F77-90. PMC: 2904182. DOI: 10.1152/ajprenal.00581.2009. View

Schoner W . Sodium pump and steroid hormone receptor. Na(+)/K(+)-ATPase. Eur J Biochem. 2002; 269(10):2423. DOI: 10.1046/j.1432-1033.2002.02908.x. View

Tarr P, Gordon C, Chandler W . Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005; 365(9464):1073-86. DOI: 10.1016/S0140-6736(05)71144-2. View

Li J, Zelenin S, Aperia A, Aizman O . Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol. 2006; 17(7):1848-57. DOI: 10.1681/ASN.2005080894. View

May K, Paton J, Paton A . Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins Bax/Bak. Infect Immun. 2010; 78(11):4691-6. PMC: 2976326. DOI: 10.1128/IAI.00801-10. View

Khundmiri S, Metzler M, Ameen M, Amin V, Rane M, Delamere N . Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells. Am J Physiol Cell Physiol. 2006; 291(6):C1247-57. DOI: 10.1152/ajpcell.00593.2005. View

GIANANTONIO C, VITACCO M, MENDILAHARZU F, Gallo G, SOJO E . The hemolytic-uremic syndrome. Nephron. 1973; 11(2):174-92. DOI: 10.1159/000180229. View

10.

Creydt V, Silberstein C, Zotta E, Ibarra C . Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect. 2005; 8(2):410-9. DOI: 10.1016/j.micinf.2005.07.005. View

11.

Fraser M, Fujinaga M, Cherney M, Melton-Celsa A, Twiddy E, OBrien A . Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem. 2004; 279(26):27511-7. DOI: 10.1074/jbc.M401939200. View

12.

Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch G . Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med. 1986; 163(6):1391-404. PMC: 2188132. DOI: 10.1084/jem.163.6.1391. View

13.

Galli L, Miliwebsky E, Irino K, Leotta G, Rivas M . Virulence profile comparison between LEE-negative Shiga toxin-producing Escherichia coli (STEC) strains isolated from cattle and humans. Vet Microbiol. 2009; 143(2-4):307-13. DOI: 10.1016/j.vetmic.2009.11.028. View

14.

Yahiro K, Morinaga N, Satoh M, Matsuura G, Tomonaga T, Nomura F . Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin. Mol Microbiol. 2006; 62(2):480-90. DOI: 10.1111/j.1365-2958.2006.05379.x. View

15.

Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta G . [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission]. Medicina (B Aires). 2007; 66 Suppl 3:27-32. View

16.

Wang H, Paton J, Paton A . Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J Infect Dis. 2007; 196(7):1093-101. DOI: 10.1086/521364. View

17.

Khundmiri S, Amin V, Henson J, Lewis J, Ameen M, Rane M . Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway. Am J Physiol Cell Physiol. 2007; 293(3):C1171-80. PMC: 2740654. DOI: 10.1152/ajpcell.00535.2006. View

18.

Laing C, Zhang Y, Gilmour M, Allen V, Johnson R, Thomas J . A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain. PLoS One. 2012; 7(5):e37362. PMC: 3359367. DOI: 10.1371/journal.pone.0037362. View

19.

Paton A, Srimanote P, Talbot U, Wang H, Paton J . A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med. 2004; 200(1):35-46. PMC: 2213318. DOI: 10.1084/jem.20040392. View

20.

Karmali M, Petric M, Lim C, Fleming P, Arbus G, Lior H . The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985; 151(5):775-82. DOI: 10.1093/infdis/151.5.775. View